BCM
Bronte Capital Management Portfolio holdings
AUM
$1.27B
This Quarter Return
+3.28%
1 Year Return
+15.69%
3 Year Return
+82.8%
5 Year Return
+107.03%
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+20%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
16.43%
Top 10 Holdings %
Top 10 Hldgs %
70.55%
Holding
33
New
3
Increased
28
Reduced
1
Closed
1
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$67.6M |
| 2 |
Vanguard Small-Cap Growth ETF
VBK
|
$39.4M |
| 3 |
Match Group
MTCH
|
$23.5M |
| 4 |
Amazon
AMZN
|
$21.7M |
| 5 |
First Citizens BancShares
FCNCA
|
$6.06M |
Top Sells
| 1 |
Enpro
NPO
|
$2.43M |
| 2 |
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
|
$9.92K |
Sector Composition
| 1 | Financials | 30.92% |
| 2 | Communication Services | 19.8% |
| 3 | Healthcare | 10.04% |
| 4 | Consumer Staples | 9.54% |
| 5 | Consumer Discretionary | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Albemarle
ALB
$9.36B
| $4.31M | 0.42% |
19,306
+157
| +0.8% | +$35K |
|
27
Altria Group
MO
$113B
| $2.84M | 0.27% |
62,674
+508
| +0.8% | +$23K |
|
28
BioNTech
BNTX
$24.2B
| $2.54M | 0.24% |
23,499
+190
| +0.8% | +$20.5K |
|
29
Riskified
RSKD
$740M
| $2.49M | 0.24% |
513,105
+4,124
| +0.8% | +$20K |
|
30
CytomX Therapeutics
CTMX
$343M
| $1.59M | 0.15% |
925,245
+7,491
| +0.8% | +$12.9K |
|
|
DBTX
31
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $596K | 0.06% |
154,878
-2,577
| -2% | -$9.92K |
|
|
32
Enpro
NPO
$4.49B
| – | – |
-23,392
| Closed | -$2.43M |
|